Document is current
Any future updates will be listed below
-
Authors
Yang, Sen
Zhang, Xiaoshuai https://orcid.org/0000-0001-5405-0802
Gale, Robert Peter
Huang, Xiaojun https://orcid.org/0000-0002-2145-6643
Jiang, Qian https://orcid.org/0000-0001-7131-0522
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81970140, 82370161)
- License Information
-
More Information
Article History
Received: 9 June 2024
Revised: 14 November 2024
Accepted: 22 November 2024
First Online: 4 December 2024
Competing interests
: RPG is a consultant to BeiGene Ltd., Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc. and CStone Pharmaceuticals; advisor to Antegene Biotech LLC, Medical Director, FFF Enterprises Inc.; partner, AZAC Inc.; Board of Directors, Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd.
: Approve by the Ethics Committee of People’s Hospital Beijing compliant with precepts the Helsinki Declaration.
